Current filters:


Popular Filters

1126 to 1150 of 1223 results

India’s Ranbaxy posts 3rd-qtr 2011 loss


India’s largest drugmaker, Ranbaxy Laboratories (RANB: BO) posted its biggest quarterly loss in…

FinancialGenericsRanbaxy Laboratories

Letter to the Editor: Canadian intellectual property


Dear, The Pharma Letter: The characterization of the CMAJ article by Paul Grootendorst and Aidan Hollis…

GenericsNorth AmericaPatentsPharmaceutical

Kohl-Grassley generic drug bill would save US taxpayers nearly $4.8 billion, says CBO


A new estimate from the USA’s Congressional Budget Office (CBO) estimate finds that a bipartisan…

GenericsNorth AmericaPatentsPharmaceuticalPoliticsPricing

Will the USA’s Hatch-Waxman lock be sprung in 2012? asks HP&M lawyer


In the USA, there have been rumors for several weeks that, once the ball gets rolling in Congress with…

GenericsLegalNorth AmericaPharmaceuticalPoliticsRegulation

Teva to continue selling Viagra generic in Russia


Israel-basedTeva Pharmaceutical Industries (Nasdaq: TEVA) managed to avoid a high-profile confrontation…

DynamicoEuropeGenericsMarkets & MarketingPatentsPfizerPharmaceuticalReproductiveTeva Pharmaceutical IndustriesViagra

US Rep Bass introduces legislation to save taxpayer money under Medicaid


US Congressman Charles Bass (Republican, New Hampshire) has introduced bipartisan legislation in the…

GenericsLegalNorth AmericaPricing

Generics giant Teva posts 3rd-qtr 2011 sales rise but net income down 13%


The world’s largest generic drugs maker, Teva Pharmaceutical Industries (Nasdaq: TEVA), has reported…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Watson posts 23% rise in 3rd-qtr 2011 net revenue; ups forecast


US generics drugmaker Watson Pharmaceuticals (NYSE: WPI) has reported net revenue of $1.1 billion for…

FinancialGenericsWatson Pharmaceuticals

Pres Obama orders FDA action to reduce Rx drug shortages in USA


in frequency and severity in recent years and adversely affecting patient care. A small number of drugs…

GenericsNorth AmericaPharmaceuticalPoliticsRegulation

Australia’s GMiA completes Code review; comments on PBS cuts and vital role of pharma manufacturing


Martin Cross, chairman of Australia’s Generic Medicines Industry Association (GMiA) has warned that…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalPricingRegulation

Brazil pharma market driven by generic medicines


According to the Ministry of Health, the Brazilian pharmaceutical market has grown to $28 billion annually,…

GenericsMarkets & MarketingPharmaceuticalSouth America

Some 40% of G7 ESA markets to be biosimilars by 2020, and insulins to reach $1 billion, says DR report


By 2020, biosimilar versions of erythropoietin stimulating agents (ESAs) will garner 40% market share…

BiotechnologyDiabetesGenericsGlobalMarkets & MarketingOncology

EuropaBio sets out views on biosimilars, saying they should not be treated like generics


To contribute to an informed debate, the biotech trade group EuropaBio is launching a new brochure acknowledging…


Dr Reddy’s 2nd-qtr net profit and sales rises beats forecasts


India’s second-largest drugmaker Dr Reddy’s Laboratories (NYSE: RDY) posted a strong set of…

Dr Reddy's LaboratoriesFinancialGenerics

28 pharma companies in USA entered potential pay-for-delay deals in FY 2011, says new FTC report


In the 2011 fiscal year (12 months to September 30) pharmaceutical companies in the USA continued a recent…

GenericsNorth AmericaPatentsPharmaceuticalPolitics

Biostar Pharma sets out targets as it completes buy of Shaanxi Weinan


Chinese drugmaker Biostar Pharmaceuticals (Nasdaq: BSPM) says that it has completed the previously-announced…

Asia-PacificBiostar PharmaGenericsMergers & AcquisitionsShaanxi Weinan

Irish drugmakers argue against ESRI Budget Perspectives (2012) proposals


Budget Perspectives 2012, a paper published last week by the Economic and Social Research Institute (ESRI),…


EU Commission opens antitrust proceedings against Johnson & Johnson and Novartis


The European Commission revealed last Friday that it has opened an antitrust investigation, on its own…

EuropefentanylGenericsJohnson & JohnsonLegalNeurologicalNovartisPatentsPharmaceutical

On the issue of delaying generics, South Africa’s pharma market not comparable with the USA, expert says


A recent report by the US competition authority, the Federal Trade Commission, on the short and long-term…

GenericsPatentsRest of the World

1126 to 1150 of 1223 results

Company Spotlight



Back to top